Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Last updated: May 21, 2024
Sponsor: Instituto Nacional de Saúde, Mozambique
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hiv Infections

Treatment

LOOP ELECTROSURGICAL EXCISION PROCEDURE

Thermal ablation

Clinical Study ID

NCT06326294
727/CNBS/23
  • Ages 25-49
  • Female

Study Summary

Given that WLWH are more likely to develop persistent HPV infection and CC, effective screening and the management and treatment of pre-cancerous cervical abnormalities is critical to decrease the global burden of cervical cancer. The vast majority of WLWH live in SSA, where resources are more constrained. Therefore, simple, affordable, and effective tools are needed for the prevention of cervical cancer in SSA. In this setting, the best method for treatment of screen-positive WLWH has not been determined. The proposed study will compare the effectiveness of TA vs. LEEP, for treating precursor lesions (CIN 2/3) and HPV infection in WLWH, identify the determinants of treatment failure, and develop a strategy to predict patients in whom treatment is likely to fail so that alternative treatments can be provided. Moreover, local evidence of the optimal method of treatments is necessary to inform health policy and promote adherence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ages 25-49 years;

  • confirmed HIV infection;

  • physically and mentally willing and able to participate in the study, and provideinformed consent.

Exclusion

Exclusion Criteria:

  • currently pregnant or <6 weeks post-partum;

  • had a hysterectomy and no longer have a cervix;

  • a history of cervical cancer or treatment for cervical abnormalities; and

  • any medical, psychiatric, or other condition that would interfere with protocoladherence, assessment of safety, and/or ability/competence to provide informedconsent.

Study Design

Total Participants: 4844
Treatment Group(s): 2
Primary Treatment: LOOP ELECTROSURGICAL EXCISION PROCEDURE
Phase:
Study Start date:
April 17, 2024
Estimated Completion Date:
December 31, 2027

Study Description

A. General purpose:

The goal of this study is to compare TA, an ablative cervical treatment modality, and LEEP, an excisional cervical treatment modality, in screen-positive WLWH patients, for eradication of hrHPV and effectiveness of treating biopsy-confirmed CIN 2/3.

B. Specific purposes

Primary Objectives:

  1. Compare the effectiveness of treating biopsy-confirmed CIN 2/3 by TA versus LEEP

  2. Compare the effectiveness of treating hrHPV infection by TA versus LEEP

  3. Assess pain and side effects/adverse events due to TA versus LEEP

Secondary Objectives:

  1. Identify the determinants of treatment failures

  2. Develop a deep learning-based automated visual evaluation tool that predicts treatment failure

Connect with a study center

  • INSMozambique

    Maputo,
    Mozambique

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.